Ejnmmi Research SCIE

國際簡(jiǎn)稱：EJNMMI RES 參考譯名：恩米研究

主要研究方向：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb 非預(yù)警期刊審稿周期： 13 Weeks

《恩米研究》(Ejnmmi Research)是一本由Springer Berlin Heidelberg出版的以RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
104 年發(fā)文量
3.1 IF影響因子
開放是否OA
29 H-index
2011 創(chuàng)刊年份
1 issue/year 出版周期
English 出版語言

EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.

The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy.

[ 查看全部 ]

投稿咨詢加急咨詢

Ejnmmi Research期刊信息

ISSN：2191-219X
出版語言：English
是否OA：開放
E-ISSN：2191-219X
出版地區(qū)：GERMANY
是否預(yù)警：否
出版商：Springer Berlin Heidelberg
出版周期：1 issue/year
創(chuàng)刊時(shí)間：2011
開源占比：0.9859
Gold OA文章占比：98.36%
OA被引用占比：1
出版國人文章占比：0.04
出版撤稿占比：0
研究類文章占比：95.19%

Ejnmmi Research CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

5.9

0.916

0.948

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Radiology, Nuclear Medicine and Imaging	Q1	72 / 333	78%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Ejnmmi Research中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核醫(yī)學(xué)	3區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核醫(yī)學(xué)	3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核醫(yī)學(xué)	3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核醫(yī)學(xué)	3區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核醫(yī)學(xué)	3區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核醫(yī)學(xué)	3區(qū)

Ejnmmi Research JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q1	49 / 204	76.2%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q2	56 / 204	72.79%

Ejnmmi Research歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Ejnmmi Research中國學(xué)者發(fā)文選摘

1、CMR validation of left ventricular volumes and ejection fraction measured by the IQ-SPECT system in patients with small heart size
Author: Wei, Hua; Wu, Jiaojiao; Han, Ke; Hu, Guang; Wang, Hongliang; Guo, Xiaoshan; Liu, Haiyan; Wu, Zhifang; Li, Sijin

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00987-2
2、Predicting PD-L1 expression status in patients with non-small cell lung cancer using [F-18]FDG PET/CT radiomics
Author: Zhao, Xiaoqian; Zhao, Yan; Zhang, Jingmian; Zhang, Zhaoqi; Liu, Lihua; Zhao, Xinming

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00956-9
3、Direct reconstruction for simultaneous dual-tracer PET imaging based on multi-task learning
Author: Zeng, Fuzhen; Fang, Jingwan; Muhashi, Amanjule; Liu, Huafeng

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00955-w
4、The potential application of MR-derived ADCmin values from Ga-68-DOTATATE and F-18-FDG dual tracer PET/MR as replacements for FDG PET in assessment of grade and stage of pancreatic neuroendocrine tumors
Author: Gao, Jing; Xu, Si; Ju, Huijun; Pan, Yu; Zhang, Yifan

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00960-z
5、Prognostic value of F-18-FDG PET/CT-based radiomics combining dosiomics and dose volume histogram for head and neck cancer
Author: Wang, Bingzhen; Liu, Jinghua; Zhang, Xiaolei; Wang, Zhongxiao; Cao, Zhendong; Lu, Lijun; Lv, Wenbing; Wang, Aihui; Li, Shuyan; Wu, Xiaotian; Dong, Xianling

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00959-6
6、Peptide-based PET imaging agent of tumor TIGIT expression
Author: Weng, Dinghu; Guo, Rong; Zhu, Ziyang; Gao, Yu; An, Rui; Zhou, Xiuman

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00982-7
7、Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies
Author: Wang, Jingnan; Huo, Li; Lin, Xue; Fang, Ligang; Hacker, Marcus; Niu, Na; Li, Xiang

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00986-3
8、Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of F-18-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag
Author: Jiang, Maoqing; Chen, Ping; Guo, Xiuyu; Zhang, Xiaohui; Gao, Qiaoling; Zhang, Jingfeng; Zhao, Guofang; Zheng, Jianjun

Journal: EJNMMI RESEARCH. 2023; Vol. 13, Issue 1, pp. -. DOI: 10.1186/s13550-023-00976-5